Faenza S, Bernardi E, Cimatti M, Dante A, Mancini E, Miklosova Z, Piraccini E, Pierucci E, Riganello I, Spedicato S, Zanoni A, Santoro A
Department of Surgery, Intensive Care and Transplantation, University of Bologna, Bologna, Italy.
Transplant Proc. 2007 Jul-Aug;39(6):1945-6. doi: 10.1016/j.transproceed.2007.05.050.
Model for End-Stage Liver Disease (MELD) score was used in our center from 2003 to assess the position of orthotopic liver transplantation (OLT) candidates on a waiting list. A key component of MELD score in the assessment of the degree of the illness is renal function. In this study, we measured the effects of this new scoring system on renal function and therapeutic strategies. We evaluated the incidence of acute renal function (ARF) after OLT requiring renal replacement therapy (hemofiltration or hemodialysis) in two patient groups: 240 transplanted before MELD era and 224 after the introduction of this parameter to select candidates. ARF occurred in 8.3% of patients in the pre-MELD group versus 13% in the MELD group, while the mortality rates were 40% and 27%, respectively. The creatinine level before OLT seemed to be a good predictor of ARF (P < .001), and blood transfusion rates (P < .05) as well as intraoperative diuresis (P < .05). In our analysis we did not observe a correlation between MELD score and postoperative ARF.
2003年起,我们中心采用终末期肝病模型(MELD)评分来评估原位肝移植(OLT)候选者在等待名单上的位置。MELD评分评估疾病严重程度的一个关键组成部分是肾功能。在本研究中,我们测定了这种新评分系统对肾功能和治疗策略的影响。我们评估了两组患者OLT术后需要肾脏替代治疗(血液滤过或血液透析)的急性肾功能(ARF)发生率:240例在MELD时代之前接受移植,224例在引入该参数以选择候选者之后接受移植。MELD前组患者中ARF发生率为8.3%,而MELD组为13%,死亡率分别为40%和27%。OLT术前的肌酐水平似乎是ARF的良好预测指标(P < .001),还有输血率(P < .05)以及术中尿量(P < .05)。在我们的分析中,未观察到MELD评分与术后ARF之间存在相关性。